Holen Sie sich die Stockscreener-App
0.6148
1.63%
-0.0102
Vorhandelsmarkt:
.58
-0.0348
-5.66%
Schlusskurs vom Vortag:
$0.625
Offen:
$0.5649
24-Stunden-Volumen:
296.00K
Relative Volume:
0.37
Marktkapitalisierung:
$24.91M
Einnahmen:
$3.99M
Nettoeinkommen (Verlust:
$-3.55M
KGV:
-1.116
EPS:
-0.5509
Netto-Cashflow:
$94,500
1W Leistung:
-7.20%
1M Leistung:
-13.97%
6M Leistung:
-50.82%
1J Leistung:
-67.47%
1-Tages-Spanne:
$0.5604
$0.6479
1-Wochen-Bereich:
$0.5423
$1.01
52-Wochen-Spanne:
$0.3818
$2.0299
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Firmenname
China Pharma Holdings Inc.
Sektor
Telefon
86 898 6681 1730
Adresse
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.6148 | 25.33M | 3.99M | -3.55M | 94,500 | -0.5509 |
TAK
Takeda Pharmaceutical Co Adr
|
16.39 | 52.66B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.70 | 43.42B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.82 | 37.47B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
74.07 | 31.61B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
526.66 | 22.73B | 3.17B | 1.29B | 1.01B | 27.09 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2010-01-08 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten
Top movers in Tuesday's pre-market session - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Vision Marine Technologies Shares Are Trading Higher By Over 60%; Here Are 20 Stocks Moving Premarket - Benzinga
China Pharma Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday? - ChartMill
VCRE|Vicore Pharma Holding AB ADR|Price:13.780|Chg%:-0.135 - TradingKey
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
The market is filled with gapping stocks in Friday's session. - ChartMill
Medroxyprogesterone Acetate Market Forecast 2026-2035: Growth Driven by Contraceptive Access and Hormone TherapyNews and Statistics - IndexBox
China Pharma Holdings (CPHI) Drops 4.87%, Approaches Critical Support at $0.65Overbought Signal Alerts - DonanımHaber
Price to book forward of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
London Shares Flash Green; AstraZeneca Rises on Deal with Chinese Pharma Group - Yahoo Finance UK
World Pharmaceutical Grade Amino Acid GlobalMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
12 Health Care Stocks Moving In Tuesday's After-Market SessionAlzamend Neuro (NASDAQ:ALZN), Vivos Ther - Benzinga
Is Yum China Holdings, Inc. (YUMC) A Good Stock To Buy Now? - Yahoo Finance
CPHI Q3 2011 Earnings: Earnings Miss Estimates, Stock DeclinesEarnings Season Review - dars.gov.et
Price to earnings forward of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
Enterprise value to EBIT forward of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
Price to sales forward of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
How many employees work at SciClone Pharmaceuticals? - Revelio Labs
China Pharma Holdings Inc (CPHI) Institutional Confidence - TradingKey
Liposomal Delivery System Market Growth Outlook to 2035: Semiconductor and Electronics Applications Accelerate DemandNews and Statistics - IndexBox
China Pharma Holdings Inc (CPHI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CPHI Q3 2011 Earnings: EPS Misses Estimates as Company Faces HeadwindsRevenue Per Share - dars.gov.et
AYTU Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Nuvectis Pharma Expands Pipeline with Exclusive Ex-China Rights to Haisco’s NXP100 and NXP200 Clinical-Stage Candidates - Quiver Quantitative
Blood pressure medication recalled nationwide over manufacturing issue - KATV
Ascentage Pharma Group International (AAPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China Pharma Holdings Inc (CPHI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China Pharma (CPHI) Stock Forecast & Analyst Ratings - Moomoo
China Pharma Holdings Inc (CPHI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
China Pharma Holdings Inc (CPHI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China Pharma Holdings Inc (CPHI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China Pharma Holdings Inc (CPHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China Pharma Holdings Inc (CPHI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China Pharma Holdings Inc (CPHI) Valuation: PE, PB & Fair Value Analysis - TradingKey
World Gel Matrix Transdermal SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Chewy Reports Strong FQ1 2026 Results; Analysts Highlight Mid-Cap Growth PotentialProduct Revenue Analysis - newsline.com
Boqii Holding Limited Provides Response to Unusual Market Action - Yahoo Finance
AMC Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts Investor SentimentGuidance Accuracy Score - newsline.com
Japanese Pharma Giants Look to China for Drug Discovery and Growth OpportunitiesEarnings Surprise Stocks - newsline.com
Shanghai Fosun Pharmaceutical Stock (CNE100000536): shares in focus amid quiet news flow - AD HOC NEWS
CPHI Q3 2011 Earnings: Significant EPS Miss Amid Challenging QuarterRevenue Report - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Amid Challenging QuarterEarnings Trend Analysis - newsline.com
OGE Energy Slips 2.9%: Defensive Utility Faces Technical HeadwindsBreakout Confirmation - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Significantly, Stock DeclinesProfit Cycle Analysis - dars.gov.et
Arrowhead Pharmaceuticals Q1 2026 Earnings: EPS Surprise on Lower Expenses Offsets Revenue VoidDividend Increase Stocks - newsline.com
Marvell Technology and Flex Set to Join S&P 500, Replacing Pool and Campbell’sPost-Announcement Reaction - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates, Stock Declines 12.9%Earnings Volatility Report - newsline.com
May Jobs Report Expected to Show Slower Hiring: Reality Check for Strong StartGross Profit Margin - newsline.com
Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):